Newsbenzinga
Intelligent Bio Submits Comprehensive Clinical Data to Enter US Drug Screening Market
· Published
Article summary
Intelligent Bio Solutions submitted a 510(k) notification to the FDA for its fingerprint drug screening system to enter the US market.
An excerpt from the original article.
Comments —
Loading comments…